What is Wakamoto Pharmaceutical Co.,Ltd.'s (4512.T) StockRank?

MoatMap's StockRank for Wakamoto Pharmaceutical Co.,Ltd. (4512.T) is 45/100, with a Hold signal. This is a composite score combining Quality (56), Value (41), and Momentum (39) factor ranks across MoatMap's 20,000+ stock universe.

Does Wakamoto Pharmaceutical Co.,Ltd. have an economic moat?

Wakamoto Pharmaceutical Co.,Ltd. (4512.T) has a Quality factor score of 56/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Wakamoto Pharmaceutical Co.,Ltd. a buy, hold, or sell?

MoatMap's current signal for Wakamoto Pharmaceutical Co.,Ltd. (4512.T) is Hold, based on a StockRank of 45/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Wakamoto Pharmaceutical Co.,Ltd. in?

Wakamoto Pharmaceutical Co.,Ltd. (4512.T) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Japan).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

4512.T

HOLDREMOVE

Wakamoto Pharmaceutical Co.,Ltd. · Healthcare · Japan · $61M · Avg Vol: $149K/d

StockRank

P/E (TTM)

37.6x

ROE

-1.8%

D/E

0.1x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Wakamoto Pharmaceutical is a small-scale domestic Japanese drugmaker with no global scale or proprietary R&D moat. It does not align with the CDMO pricing power theme and lacks the quality metrics for a concentrated book.

COMPANY DESCRIPTION

Wakamoto Pharmaceutical Co., Ltd. manufactures and sells over-the-counter (OTC) gastrointestinal medicines, ophthalmic drugs, and dietary supplements. The company's flagship product, 'Strong Wakamoto,' is a highly recognized, long-selling digestive enzyme supplement in Japan and other Asian markets. Its competitive position is anchored by deep brand equity and specialized manufacturing capabilities in ophthalmic solutions.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	52M	54M	48M	49M	-2.4%
EPS	0.04	0.02	0.02	0.01	-35.4%
Shares	35M	35M	35M	35M	0.0%
Debt	807,350	861,459	817,315	803,736	-0.1%
Equity	72M	74M	75M	73M	0.4%
Op CF	2M	4M	-671,060	-4M	86.3%
Inv CF	316,168	107,100	-14,704	-84,387	—
Fin CF	-10,128	-10,097	-656,355	-649,785	—

PRICE (1M)-28.3%

SMA 50SMA 200

$1.60

RSI (14)

30.5

52W High

$2.35

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

0.1%44.8

ROE

-1.8%42.7

GP/Assets

33.4%70.5

Op. Margin

-5.8%31.6

FCF/Assets

-1.6%45.0

Piotroski

—83.4

Int. Cover

9.5x63.6

D/E Ratio

0.14x60.7

Current Ratio

4.30x66.2

Value

P/E (TTM)

37.6x28.9

EV/EBITDA

16.3x24.9

P/FCF

—N/A

P/B

0.7x86.5

P/S

0.9x85.5

Div Yield

—N/A

Momentum

52W High %

68%53.1

RS 6M

-47%24.5

SMA 50/200

1.02x66.6

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$61M

P/E (Forward)

—

Gross Margin

53.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 4512.T are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
4512.T	Wakamoto Pharmaceutical Co.,Ltd.(you)	$61M	45	HOLD
4538.T	Fuso Pharmaceutical Industries,Ltd.	$109M	34	SELL
2929.T	Pharma Foods International Co., Ltd.	$114M	30	SELL
4597.T	Solasia Pharma K.K.	$55M	11	STRONG SELL
4574.T	Taiko Pharmaceutical Co.,Ltd.	$81M	83	STRONG BUY
4569.T	KYORIN Pharmaceutical Co., Ltd.	$457M	56	HOLD
4595.T	Mizuho Medy Co.,Ltd.	$207M	81	STRONG BUY
9273.T	Koa Shoji Holdings Co.,Ltd.	$210M	84	STRONG BUY
4887.T	Sawai Group Holdings Co., Ltd.	$1.3B	48	HOLD
4577.T	Daito Pharmaceutical Co.,Ltd.	$218M	85	STRONG BUY

Peer medians: ROE 8.4% · P/E 15.5x · Gross margin 47.8%

Wakamoto Pharmaceutical Co.,Ltd. (4512.T) — Stock Score Summary

Wakamoto Pharmaceutical Co.,Ltd. (4512.T) has a MoatMap StockRank of 45/100 based on Quality (56/100), Value (41/100), and Momentum (39/100) factor scores. The current signal is HOLD. Wakamoto Pharmaceutical is a small-scale domestic Japanese drugmaker with no global scale or proprietary R&D moat. It does not align with the CDMO pricing power theme and lacks the quality metrics for a concentrated book.

Key Financial Metrics

Price	$1.60
Market Cap	$61M
P/E (TTM)	37.61
Price/Book	0.71
Return on Equity	-1.8%
Return on Invested Capital	0.1%
Debt/Equity	13.69
Gross Margin	53.9%
Operating Margin	-5.8%
Revenue Growth	-10.3%
Free Cash Flow	$-9K

Wakamoto Pharmaceutical Co.,Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Japan).

Frequently Asked Questions

What is Wakamoto Pharmaceutical Co.,Ltd.’s (4512.T) StockRank?: MoatMap’s StockRank for Wakamoto Pharmaceutical Co.,Ltd. (4512.T) is 45/100, with a Hold signal. It is a composite of Quality (56), Value (41), and Momentum (39) factor ranks across MoatMap’s 20,000+ stock universe.
Does Wakamoto Pharmaceutical Co.,Ltd. have an economic moat?: Wakamoto Pharmaceutical Co.,Ltd. (4512.T) has a Quality factor score of 56/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Wakamoto Pharmaceutical Co.,Ltd. a buy, hold, or sell?: MoatMap’s current signal for Wakamoto Pharmaceutical Co.,Ltd. (4512.T) is Hold, based on a StockRank of 45/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Wakamoto Pharmaceutical Co.,Ltd. in?: Wakamoto Pharmaceutical Co.,Ltd. (4512.T) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Japan).